Xealth lands investment from Cerner as COVID-19 accelerates digital health adoption, Werewolf Therapeutics appoints new CBO, and more portfolio news

This month’s portfolio company spotlight features stories from Evolent Health, Werewolf Therapeutics, and Xealth.


Evolent Health logo image

Frank Williams, the CEO of Arlington health system consultancy Evolent Health Inc. (NYSE: EVH), will step down from that role Oct. 1. He will be replaced by fellow co-founder Seth Blackley, according to a Securities and Exchange Commission filing. Williams, 54, has held the CEO role since 2011, and he will move into the executive chairman role with the publicly traded company.


Werewolf Therapeutics logo

In this role, Lubman will oversee corporate and business development, portfolio strategic planning, financial strategy, and investor relations.


Xealth logo image

The Digital Health 150 is CB Insights’ annual ranking of the 150 most promising digital health startups in the world. This year, Xealth was included among the winning startups working on interoperability, at-home care, emerging benefits, and more.


The COVID-19 pandemic is forcing hospital systems to adopt digital tools at record pace. They are getting help from startups such as Xealth, a Seattle-based company that just announced a key partnership with Cerner and an investment from the publicly-traded healthcare giant.

You Might Also Like…

more from the newsletter